Warmly welcome you to visit our booth 1D73 in API  (Hangzhou) from May. 8th to May. 10th, 2019. Exhibition name: the 82nd API China- China international pharmaceutical raw materials, intermediates, packaging, equipment fair. Booth number:1D73 Time: May 8-10,2019 Venue: Hangzhou international expo center We provided a wealth of polyethylene glycol derivatives, side chains of hypoglycemic drugs (Semaglutide side chain, Liraglutide side chain, Insulin Detemir side chain, Insulin Deglutide chain), polyethylene glycol block copolymers, polyethylene glycol phospholipids, etc. Welcome to our booth.

Welcome to visit us at

Join Us at TIDES USA 2025 in San Diego!  Mark your calendars! TIDES USA 2025—the premier event for oligonucleotide and peptide therapeutics—is coming to San Diego, USA, on May 19, 2025.    Visit SINOPEG at Booth #613 to explore cutting-edge solutions in:    Custom PEG Derivatives (mPEG, heterobifunctional PEGs, branched PEGs)    Lipid Nanoparticles (LNPs) & Lipidoids for nucleic acid delivery    Innovative Linker Technologies & ADC Payloads Why Stop By?  Discuss your formulation challenges with our PEGylation experts  Discover high-purity excipients for mRNA, siRNA, and peptide therapies  Learn how our GMP-grade materials accelerate preclinical-to-commercial transitions Spotlight Case Study: Ask us about our role in developing temperature-stable LNP formulations for a global COVID-19 vaccine partner! Schedule a 1:1 Meeting: Avoid the crowds—reserve your private session today: sales@sinopeg.com Can't attend? Explore our solutions online: http://www.sinopeg.com Let's shape the future of oligonucleotide and peptide therapeutics together! See you at #613.  #TIDES2025 DrugDiscovery #LNPs #mRNA #PeptideTherapeutics #BiotechInnovation

Exciting Announcement! SINOPEG is thrilled to announce that we will be exhibiting at TIDES USA 2025, taking place May 19–22 at the Manchester Grand Hyatt San Diego! Join us at Booth #613 to explore how SINOPEG continues to drive innovation in oligonucleotide and peptide therapeutics. As a trusted partner in the industry, we specialize in delivering high-quality building blocks, advanced intermediates, and customized solutions to accelerate your drug discovery and development projects. Why Visit Us? Discover our cutting-edge portfolio of products and services. Discuss collaboration opportunities with our expert team. Learn how we support global partners in overcoming complex R&D challenges. TIDES USA is the premier event for oligonucleotide and peptide therapeutics, and we're eager to connect with industry leaders, researchers, and innovators shaping the future of biopharma. Let's explore synergies and unlock new possibilities together! Save the Date: May 19–22, 2025 Location: Manchester Grand Hyatt San Diego Find Us: Booth #613 Can't wait to meet you there? Drop us a message or comment below – let's start the conversation today!

Product Name: XcellFect RNA Transfection Reagent Catalog No.: D7010101 Storage: Sealed at 4°C. Avoid repeated freeze-thaw cycles. Why Choose XcellFect? High Efficiency, Low Toxicity: Powered by our patented lipid-based formulation, XcellFect overcomes traditional delivery bottlenecks to deliver ultra-high transfection efficiency while maintaining minimal cytotoxicity. Say goodbye to compromised cell viability! Broad Spectrum Compatibility: Designed for versatility, XcellFect works seamlessly across common cell lines and is specially optimized for hard-to-transfect cells. No more struggling with inconsistent results! Multi-RNA Flexibility: Whether you’re working with siRNA, mRNA, miRNA, or other RNA types, XcellFect ensures robust delivery for diverse applications—from gene silencing to therapeutic development. Streamlined Workflow: Just mix Reagent A and B, combine with RNA, and add to cells—no media replacement needed! Compatible with complete culture media, saving you time and simplifying protocols. Ideal For: Gene function studies Therapeutic RNA delivery CRISPR-Cas9 workflows High-throughput screening ransform Your Research Today! contact our team at polydarwin@sinopeg.com to learn more or request a sample. Let XcellFect accelerate your breakthroughs in RNA-based science!

Lipid nanoparticle (LNP) delivery systems are widely used in the fields of gene therapy and vaccines.However, to achieve effective gene delivery and vaccine delivery, not only suitable carriers and nucleic acids or antigens need to be selected, but also excipients for LNP delivery systems are needed.These excipients play a key role in stability, transparency, protective effect, and charge capacity. Firstly, stability is an important characteristic of excipients for LNP delivery systems.Excipients interact with lipid components, increasing the stability of LNP.For example, polyethylene glycol (PEG) is one of the commonly used excipients, which can form a stable layer of polymer by covering the surface of LNP.This polymer layer helps to reduce protein and cell adsorption and provides additional stability, thereby prolonging the circulation life of LNP. Secondly, transparency is an important factor to be considered when designing LNP delivery systems.Transparency can affect the preparation of LNP and the visualization of the internal structure.Therefore, excipients are usually selected for their characteristics of lower absorption and scattering of light to obtain clear imaging and accurate structural analysis. In addition, excipients for LNP delivery systems can also provide protection, protecting nucleic acids or antigens from degradation. For example, cholesterol is a common excipient that can be inserted into LNP to form a barrier that protects the nucleic acid or antigen.This protective layer can prevent the nucleic acid or antigen from being attacked by enzymes and help improve delivery efficiency and immune activation. In addition, charge is also an important characteristic of excipients.Charge can affect the interaction between LNP and target cells and delivery efficiency.For example, some excipients can regulate the charge state on the surface of LNP to improve its adsorption and cell uptake, thus improving delivery effect. In summary, excipients in LNP delivery systems play an important role in gene therapy and vaccine research.By selecting appropriate excipients, the stability, transparency, protective effect and charge of LNP can be optimized to achieve efficient gene delivery and vaccine delivery.Researchers will continue to develop new excipients to further improve the performance of LNP delivery systems and promote the development of gene therapy and vaccine research. Lipids that has been registered with DMF: DLin-MC3-DMA* SM-102 (HUO)* ALC-0315 (DHA)* DHA-1 (ALC-0315 analogue) mPEG-DMG-2K ALC-0159 (mPEG-DTA)* mPEG-DTA-1-2K (ALC-0159 analogue) DSPC DOPE DOTAP-Cl Cholesterol (Plant) Click here for more lipid products * This product is protected by third-party patents. We provide patent-compliant technical consultation and services, not the product itself.